Tango Therapeutics Inc.
TNGX | NASDAQ
$22.33
+$0.58 (+2.67%)
At close: Sep 21, 2026, 4:00 PM ET
$22.55
+$0.22 (+0.99%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 62.38M | 42.07M | 36.53M | 24.86M | 37.04M | 7.66M |
Cost of Revenue | 2.28M | n/a | n/a | n/a | n/a | 1.63M |
Gross Profit | 60.1M | 42.07M | 36.53M | 24.86M | 37.04M | 6.03M |
Operating Income | -111.29M | -145.6M | -114.17M | -111.07M | -58.19M | -52.2M |
Interest Income | 5.63M | 7.89M | 6.62M | 1.46M | 495K | 108K |
Pretax Income | -101.59M | -130.09M | -101.61M | -108.12M | -57.94M | -51.97M |
Net Income | -101.59M | -130.3M | -101.74M | -108.18M | -58.24M | -51.97M |
Selling & General & Admin | 41.51M | 43.75M | 35.5M | 30.03M | 17.6M | 8.24M |
Research & Development | 132.17M | 143.92M | 115.2M | 105.91M | 77.64M | 49.99M |
Other Expenses | -2.28M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 171.39M | 187.66M | 150.7M | 135.93M | 95.23M | 58.23M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 173.67M | 187.66M | 150.7M | 135.93M | 95.23M | 59.86M |
Income Tax Expense | 4K | 208K | 134K | 54K | 292K | n/a |
Shares Outstanding (Basic) | 116.17M | 109.23M | 94.57M | 87.82M | 62.11M | 87.47M |
Shares Outstanding (Diluted) | 116.17M | 109.23M | 94.57M | 87.82M | 62.11M | 87.47M |
EPS (Basic) | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 | -1.62 |
EPS (Diluted) | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 | -1.62 |
EBITDA | -99.31M | -127.6M | -99.2M | -106.51M | -57.05M | -50.35M |
EBIT | -101.59M | -130.09M | -101.61M | -108.12M | -57.94M | -51.97M |
Depreciation & Amortization | 2.28M | 2.5M | 2.42M | 1.61M | 897K | 1.63M |
Add to Watchlist
Select watchlists to add or remove TNGX